{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:50:55Z","timestamp":1780613455292,"version":"3.54.1"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"3","funder":[{"name":"Centre for Research and Instrumentation, Universiti Kebangsaan Malaysia","award":["GGPM-2011-083, 2012"],"award-info":[{"award-number":["GGPM-2011-083, 2012"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2020-0086_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Gestational trophoblastic disease comprises of a spectrum of pregnancy-related tumours which includes complete (CHM) and partial hydatidiform moles (PHM). Accurate diagnosis and subclassification of HM subtypes are crucial as prognosis differs. Histopathological examination using haemotoxylin and eosin (H&amp;E) staining remains the basis for diagnosing HM, with only 80% accuracy. p57kip2 is a cyclin-dependent kinase inhibitor (CDKI) protein and is strongly paternally imprinted, being expressed from maternal allele. Therefore, complete mole (CHM) with only paternal genome has nearly absent expression of p57kip2 compared to partial mole (PHM) having both paternal and maternal genomes. This study is aimed to determine usefulness of p57kip2 immunohistochemistry (IHC) analysis in the diagnosis of HM subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2020-0086_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 82 archived paraffin embedded HM tissues with subtypes classified based on H&amp;E staining\u00a0\u2013 39 (47.5%) CHM, 41 (50.0%) PHM and two (2.43%) unclassified molar pregnancy were retrieved. All tissue samples were subjected for p57kip2 IHC analysis and HM subtypes were then reclassified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2020-0086_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 66 cases (80.5%) were re-classified as CHM, 14 cases (17.1%) as PHM and two cases (2.4%) were decidual and cystic tissues. Analysis using p57kip2 immunostaining showed a diagnostic discrepancy of 33.0% from routine H&amp;E staining and helps to improve the characterisation of the HM subtypes specifically at early gestations which have less distinctive morphologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2020-0086_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IHC using p57kip2 monoclonal antibody should be considered as a routine ancillary test to H&amp;E in improving the diagnosis of HM subtypes particularly in developing countries with limited resources.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2020-0086","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:41:42Z","timestamp":1621543302000},"page":"311-316","source":"Crossref","is-referenced-by-count":3,"title":["Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes"],"prefix":"10.1515","volume":"42","author":[{"given":"Nurzaireena","family":"Zainal","sequence":"first","affiliation":[{"name":"Department of O&G , Universiti Kebangsaan Malaysia Medical Centre , Kuala Lumpur , Malaysia"},{"name":"Department of O&G , Universiti Sains Islam Malaysia , Nilai , Negeri Sembilan , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala Chandralega","family":"Kampan","sequence":"additional","affiliation":[{"name":"Department of O&G , Universiti Kebangsaan Malaysia Medical Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa M.","family":"Rose","sequence":"additional","affiliation":[{"name":"Department of Pathology , Universiti Kebangsaan Malaysia Medical Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razmin","family":"Ghazali","sequence":"additional","affiliation":[{"name":"Department of Pathology , Hospital Kuala Lumpur , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Nasir","family":"Shafiee","sequence":"additional","affiliation":[{"name":"Department of O&G , Universiti Kebangsaan Malaysia Medical Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Haliza","family":"Yussoff","sequence":"additional","affiliation":[{"name":"Department of Pathology , Hospital Kuala Lumpur , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azmi","family":"Tamil","sequence":"additional","affiliation":[{"name":"Department of Public Health , Universiti Kebangsaan Malaysia Medical Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Abdul","family":"Jamil","sequence":"additional","affiliation":[{"name":"Department of O&G , Universiti Kebangsaan Malaysia Medical Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Hamidah","family":"Hussin","sequence":"additional","affiliation":[{"name":"Department of Pathology , Universiti Kebangsaan Malaysia Medical Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"2025121207241770758_j_hmbci-2020-0086_ref_001","unstructured":"Loh, K, Sivalingam, N, Suryani, M. Gestational trophoblastic disease. Med J Malaysia 2004;59:697\u2013702."},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_002","doi-asserted-by":"crossref","unstructured":"Ngan, HY, Bender, H, Benedet, JL, Jones, H, Montruccoli, GC, Pecorelli, S. Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet 2003;83(1 Suppl):175\u20137. https:\/\/doi.org\/10.1016\/s0020-7292(03)90120-2.","DOI":"10.1016\/S0020-7292(03)90120-2"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_003","doi-asserted-by":"crossref","unstructured":"Bentley, RC. Pathology of gestational trophoblastic disease. Clin Obstet Gynecol 2003;46:513\u201322. https:\/\/doi.org\/10.1097\/00003081-200309000-00004.","DOI":"10.1097\/00003081-200309000-00004"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_004","doi-asserted-by":"crossref","unstructured":"Steigrad, SJ. Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol 2003;17:837\u201347. https:\/\/doi.org\/10.1016\/s1521-6934(03)00049-x.","DOI":"10.1016\/S1521-6934(03)00049-X"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_005","doi-asserted-by":"crossref","unstructured":"Nirmala, C, Nor Azlin, M, Harry, S, Lim, P, Shafiee, M, Nur Azurah, A, et al.. Outcome of molar pregnancies in Malaysia: a tertiary centre experience. J Obstet Gynaecol 2013;33:191\u20133. https:\/\/doi.org\/10.3109\/01443615.2012.741150.","DOI":"10.3109\/01443615.2012.741150"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_006","unstructured":"Levine, DA, Lin, L, Gaillard, S. Handbook for principles and practice of gynecologic oncology. Philadelphia, USA: Lippincott Williams & Wilkins; 2020."},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_007","doi-asserted-by":"crossref","unstructured":"Matsui, H, Iitsuka, Y, Yamazawa, K, Tanaka, N, Seki, K, Sekiya, S. Changes in the incidence of molar pregnancies. A population\u2010based study in Chiba Prefecture and Japan between 1974 and 2000. Hum Reprod 2003;18:172\u20135. https:\/\/doi.org\/10.1093\/humrep\/deg008.","DOI":"10.1093\/humrep\/deg008"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_008","doi-asserted-by":"crossref","unstructured":"Matsuda, T, Wake, N. Genetics and molecular markers in gestational trophoblastic disease with special reference to their clinical application. Best Pract Res Clin Obstet Gynaecol 2003;17:827\u201336. https:\/\/doi.org\/10.1016\/s1521-6934(03)00096-8.","DOI":"10.1016\/S1521-6934(03)00096-8"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_009","unstructured":"Cheah, PL, Looi, LM, Sivanesaratnam, V. Hydatidiform molar pregnancy in Malaysian women: a histopathological study from the University Hospital, Kuala Lumpur. Malays J Pathol 1993;15:59."},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_010","doi-asserted-by":"crossref","unstructured":"Khawajkie, Y, Mechtouf, N, Nguyen, NMP, Rahimi, K, Breguet, M, Arseneau, J, et al.. Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes. Mod Pathol 2020;33:880\u201392. https:\/\/doi.org\/10.1038\/s41379-019-0432-4.","DOI":"10.1038\/s41379-019-0432-4"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_011","doi-asserted-by":"crossref","unstructured":"Paradinas, F. The diagnosis and prognosis of molar pregnancy: the experience of the National Referral Centre in London. Int J Gynecol Obstet 1998;60:S57\u201364. https:\/\/doi.org\/10.1016\/s0020-7292(98)80006-4.","DOI":"10.1016\/S0020-7292(98)80006-4"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_012","unstructured":"Gshwendtner, A, Neher, A, Kreczy, A, Muller-Holzner, E. DNA ploidy determination of early molar pregnancies by image analysis: comparison to histologic classification. Arch Pathol Lab Med 1998;122:1000."},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_013","doi-asserted-by":"crossref","unstructured":"Berkowitz, RS, Goldstein, DP. Current management of gestational trophoblastic diseases. Gynecol Oncol 2009;112:654\u201362. https:\/\/doi.org\/10.1016\/j.ygyno.2008.09.005.","DOI":"10.1016\/j.ygyno.2008.09.005"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_014","doi-asserted-by":"crossref","unstructured":"Ronnett, BM. Hydatidiform moles: differential diagnosis, diagnostic reproducibility, genetics and ancillary techniques to refine diagnosis. Diagn Histopathol 2019;25:35\u201352. https:\/\/doi.org\/10.1016\/j.mpdhp.2018.12.003.","DOI":"10.1016\/j.mpdhp.2018.12.003"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_015","doi-asserted-by":"crossref","unstructured":"Nguyen, NMP, Bolze, P-A, Slim, R. Hydatidiform moles. Textbook of autoinflammation. Switzerland: Springer Nature; 2019:485\u201397 pp.","DOI":"10.1007\/978-3-319-98605-0_27"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_016","doi-asserted-by":"crossref","unstructured":"Goldstein, DP, Berkowitz, RS, Horowitz, NS. Gestational trophoblastic disease. Abeloff\u2019s clinical oncology. Philadelphia, USA: Elsevier; 2020:1544\u201359.e3 p.","DOI":"10.1016\/B978-0-323-47674-4.00087-6"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_017","doi-asserted-by":"crossref","unstructured":"Fukunaga, M. Flow cytometric and clinicopathologic study of complete hydatidiform moles with special reference to the significance of cytometric aneuploidy. Gynecol Oncol 2001;81:67\u201370. https:\/\/doi.org\/10.1006\/gyno.2000.6100.","DOI":"10.1006\/gyno.2000.6100"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_018","doi-asserted-by":"crossref","unstructured":"Usui, H, Sato, A, Ota, M, Ikeda, J-I, Shozu, M. Androgenetic complete hydatidiform moles with p57KIP2-positive immunostaining. Am J Clin Pathol 2020;154:776\u201383. https:\/\/doi.org\/10.1093\/ajcp\/aqaa096.","DOI":"10.1093\/ajcp\/aqaa096"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_019","doi-asserted-by":"crossref","unstructured":"Osterheld, M, Caron, L, Chaubert, P, Meagher-Villemure, K. Combination of immunohistochemistry and ploidy analysis to assist histopathological diagnosis of molar diseases. Clin Med Pathol 2008;1:61\u20137. https:\/\/doi.org\/10.4137\/cpath.s601.","DOI":"10.4137\/CPath.S601"},{"key":"2025121207241770758_j_hmbci-2020-0086_ref_020","doi-asserted-by":"crossref","unstructured":"Madi, J, Braga, A, Paganella, M, Litvin, I, Wendland, E. Accuracy of p57 KIP 2 compared with genotyping to diagnose complete hydatidiform mole: a systematic review and meta\u2010analysis. BJOG An Int J Obstet Gynaecol 2018;125:1226\u201333. https:\/\/doi.org\/10.1111\/1471-0528.15289.","DOI":"10.1111\/1471-0528.15289"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2020-0086\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2020-0086\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:23:19Z","timestamp":1765527799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2020-0086\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,8]]},"published-print":{"date-parts":[[2021,9,24]]}},"alternative-id":["10.1515\/hmbci-2020-0086"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2020-0086","relation":{},"ISSN":["1868-1891"],"issn-type":[{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]}}}